The revolutionary “real-world” Salford Lung Study is held aloft as the first of its kind globally. It shows a major advance in the way we do clinical trials, evaluating a new treatment for COPD patients that combines the robust scientific methodology of a Randomised Controlled Trial (the gold standard in clinical trials) with the benefits of observing “real patients” in a “real-setting.”
On this page you will find two patient interviews who have taken part in the study, an interview with Dr Sue Collier who works for life-sciences company GlaxoSmithKline (GSK) as Head of Medical Operations and an interview with Linda Stephens who also works at GSK, advising on the key role that community pharmacy plays in this ground-breaking research project.
Kenneth is 71 years old and has suffered with asthma since he was 13. He received a letter from his GP which described his condition as COPD which came as a surprise.
He is one of many people that don’t realise that their breathing condition comes under the umbrella of Chronic Obstructive Pulmonary Disease (COPD).
The letter offered the opportunity to take part in the Salford Lung Study. He agreed because wanted to help others with the same condition, including his family and friends. Since taking part in the study and using the new medication, he’s never felt better!
Janet found out she had asthma when she was 21 years old and has struggled with it for the last 40 years. Her symptoms include shortness of breath, coughing and a tight chest and she was understandably concerned about her health in the long term.
When she was offered the opportunity to take part in the Salford Lung study she jumped at the chance. For the first time in four decades, Janet now has a better quality of life and can administer her own treatment in the comfort of her own home.
Dr Sue Collier works for life-sciences company GlaxoSmithKline (GSK) as Head of Medical Operations for the Salford Lung Study – the first large, prospective, real-world trial to be conducted across a patient population within a single geographical setting. Formerly a GP in the North West of England, Sue's role is to provide advice for the study team and GPs (investigators) conducting the study on matters such as patient eligibility, recruitment strategies, and data collection. She’s also responsible for helping to monitor the safety of patients.
Sue explains what real-world research is all about, why the Salford Lung Study is the first of its kind globally, and how it fits into the bigger picture.
Linda Stephens is a qualified pharmacist. She has worked at GlaxoSmithKline (GSK) for the past 13 years but before that she spent several years as a hospital pharmacist and chief pharmacist at Leicester General Hospital – pharmacy is her passion.
Her role in the Salford Lung Study has been to galvanize the pharmacy community and advise on the key role that community pharmacy plays in this ground-breaking research project.
Linda describes the crucial role that pharmacy is playing in making this real work study a reality.